AI assistant
Sending…
Hoth Therapeutics, Inc. — Director's Dealing 2024
Aug 19, 2024
34935_dirs_2024-08-19_b2e0855d-0a6a-48ce-bd9f-f0dd13533a01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2024-08-16
Reporting Person: Knie Robb (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-16 | Common Stock | P | 25000 | $0.67 | Acquired | 58131 | Direct |
More from Hoth Therapeutics, Inc.
Board/Management Information
2026
Jun 3
Capital/Financing Update
2026
Jun 3
Capital/Financing Update
2026
Jun 3
Regulatory Filings
2026
Jun 2
Capital/Financing Update
2026
May 28
Share Issue/Capital Change
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 6